RPF Keynote Speakers

Wednesday, May 6, 2015
12:30-1:30pm
G013 School of Nursing

Lisa Stehno-Bittel

Lisa A. Stehno-Bittel, PT, PhD
Department Chair and Professor
Physical Therapy and Rehabilitation Science
University of Kansas Medical Center

Dr. Stehno-Bittel is chair of the Department of Physical Therapy and Rehabilitation Science. In addition to teaching in the DPT and post-professional DPT programs, she is also a professor of anatomy and cell biology at KU Medical Center. She is a course director of differential diagnosis, case studies in pathophysiology, medical imaging, and pharmacology for physical therapists. Stehno-Bittel provides numerous guest lectures in other graduate programs within and outside of the department and is the scientific director of the Great Plains Diabetes Coalition and a director of the Diabetes Research Laboratory.

Stehno-Bittel's research focuses on exploring the restoration of normal glycemic conditions through pancreatic islet transplantation, and the creation of bio-artificial pancreatic islets. Stehno-Bittel is also conducting community-based research aimed at preventing type 2 diabetes and improving the lives of those individuals already dealing with the affliction.

 

Friday, May 8, 2015
12:00-1:00pm
G013 School of Nursing

John Spertus

John Spertus, MD, MPH, FACC, FAHA
Daniel Lauer/Missouri Endowed Chair
Clinical Director of Outcomes Research
Saint Luke's Mid America Heart Institute

Dr. Spertus' research focuses on methods for assessing patients' health outcomes, measuring healthcare quality, and the use of information technology to guide medical decision-making based on risk-prediction models so that treatment can be safer, more cost-effective, evidence-based and patient-centered. He developed the Seattle Angina Questionnaire (SAQ), and the Kansas City Cardiomyopathy Questionnaire (KCCQ), which have both been translated into over 50 languages and are emerging as the gold standards for measuring patients' symptoms, function and quality of life in coronary artery disease and heart failure. Most recently, Dr. Spertus has extended his translational research to illuminate the prognostic significance of genetic and other biomarkers on cardiovascular outcomes. Since arriving in Kansas City, Dr. Spertus has continuously supported his research program through extramural funding and currently supports over 18 employees. His group was one of 4 recipients of the American Heart Association's Outcomes Research Center Awards, an extremely competitive award.

 

 

 

 

 

 

 

 

 

 

Last modified: Dec 02, 2014
ID=x9052